IP Library › Assignment 069239/0830
Patent Assignment
Reel/Frame 069239/0830

Assignment of Assignor's Interest

Recorded: 2024-11-12 Pages: 6
Assignor
TABUTEAU, HERRIOT
Executed: 2024-11-12
Assignee
AXSOME THERAPEUTICS, INC.
ONE WORLD TRADE CENTER, 22ND FLOOR, NEW YORK, NEW YORK, 10007
Covered Properties (10)
Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion
Application: 18/813,008 →
Publication: US US20250127732A1
Use of Reboxetine to Treat Narcolepsy
Application: 18/820,232 →
Publication: US US20240415842A1
Use of Reboxetine to Treat Narcolepsy
Application: 18/827,622 →
Use of Reboxetine to Treat Narcolepsy
Application: 18/885,105 →
Use of Reboxetine to Treat Nervous System Disorders
Application: 63/696,325 →
Pharmaceutical Compositions Comprising Meloxicam
Application: 18/895,044 →
Publication: US US20250009754A1
Pharmaceutical Compositions Comprising Bupropion and Cysteine
Application: 18/921,291 →
Publication: US US20250041426A1
Pharmaceutical Compositions Comprising Meloxicam
Pharmaceutical Compositions Comprising Meloxicam
Solriamfetol for Improving Cognitive Health in Apnea Patients
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest May 9, 2025
From: AXSOME THERAPEUTICS, INC.; AXSOME MALTA LTD.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 071247/0836 →
Assignment of Assignor's Interest Mar 4, 2026
From: AXSOME THERAPEUTICS, INC.
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 073973/0726 →